• br We included patients with monoallelic or biallelic TSG inactivation

  2022-05-07

  

  We included patients with monoallelic or biallelic TSG inactivation as “biomarker positive” in the primary analysis, based on preclinical and clinical evidence implicating TSG haploinsufficiency in prostate cancer progression [5,27]. This explains the higher frequency of TSG alterations observed i

• br Fig Dose distribution for the escalated dose plan

  2022-05-07

  

  Fig. 4. Dose distribution for the escalated dose plan in 5 fractions (top) and 15 fractions (bottom) for patient 2. PTV Coverage by the CFTRinh-172 dose (light green) is higher in 15 fractions (95%) than in 5 fractions (86%). However, PTV coverage by the escalated dose (dark red) is higher in 5 f

• br RESULTS br Commensal Microbiota Promote

  2022-05-06

  

  RESULTS Commensal Microbiota Promote Tumor Growth in an Autochthonous GEM Model of LUAD We have previously established a GEM model of human LUAD using conditional Pifithrin-α of KrasLSL-G12D; p53flox/flox in mice (KP mice) (Jackson et al., 2001). In this model, intratracheal infection wi

• br Fig PCA detection from urine of BPH patients

  2022-05-04

  

  Fig. 7. PCA3 detection from urine of BPH patients. (A) PCR products of PCA3 (upper gel) and GAPDH (lower gel) analyzed by 1.5% agarose gel electrophoresis. Amplicon sizes of PCA3 and GAPDH were 838 bp and 106 bp, respectively. Lane M, 100 bp ladder; Lane PC, PCR products from LNCaP cells; Lanes B1

• br Table All criteria of colorectal cancer br

  2022-05-04

  

   Table 1 – All criteria of colorectal cancer. Variables n Undifferentiated adenocarcinoma 5 (7.1) Moderately differentiated adenocarcinoma 38 (53.5) Poorly differentiated adenocarcinoma 8 (11.3) Well differentiated adenocarcinoma 6 (8.5) Variables n Poorly differentiat

• Thus we aimed to i evaluate the anti tumor

  2022-05-04

  

  Thus, we aimed to i) evaluate the anti-tumor activity of CCL660 in patient-derived xenograft (PDX) models of lung cancer [28]; ii) eluci-date the mechanism of action of CCL-delivered miR-660 within tumor cells; and iii) evaluate the acute and chronic toxicity of this lipid-na-noparticles formulation

• br For evaluation the anti tumor activity

  2022-05-04

  

  For evaluation the anti-tumor activity of TRAIL releasing from TH-s-RSC, MTT assay was performed on TRAIL-sensitive MDA-MB-231 SPDP and TRAIL-resistant A549 cells. In brief, MDA-MB-231 cells or A549 cells were seeded in 96-well plate and cultured at 37 °C for 24 h. Then the cells were incubated w

• br for Windows The c and Fisher s

  2022-05-04

  

  12.0 for Windows. The c2 and Fisher's Exact Tests were used appropriately. Differences were considered statistically significant at p 0.05. 4. Results We analyzed 13 MpBC (Table I) cases representing 1.16% of the 1122 invasive breast cancer cases. All patients were female with a median age o

• Detected br Conclusion br In this work breast

  2022-04-28

  

  Detected 6. Conclusion In this work breast cancer detection using maximization esti-mation is done to acquire more accuracy. Increasing the intensity class in the estimation maximization produce better results. Usual shape features can’t be used for this purpose because we are con-sidering the

• Lung Cancer br the predicted values The selection of the

  2022-04-28

  

   Lung Cancer 134 (2019) 108–116 the predicted values. The selection of the optimal number of mutation factors was performed by cross-validation in this study. To account for the over-fitting problem and to select the best predictive features, the model was built based on a 5-fold cross-validati

• br Figure Differential expression of exosomal miRNAs selected with

  2022-04-27

  

  Figure 1. Differential Benazepril of exosomal miRNAs selected with significance analysis of microarrays according to synchronous metastasis (M-status) or tumor regression grade (TRG). The relative expression of each miRNA was normalized according to the global mean, and significant differences bet

• br Chromosomal aberration test br Chromosomal aberration test

  2022-04-26

  

  2.5. Chromosomal aberration test Chromosomal aberration test was made as follows. T24 and 253 J cells (5 × 105) were seeded in petri dishes (100 mm) 24 h before treatment. Cell cultures were exposed either to the studied phenazines (20 μM) or TSA (0.16 μM) in the presence or absence of cisplati

• br Prescott J Lu Y

  2022-04-25

  

  25.– Prescott–J,–Lu–Y,–Chang–ET,–et–al.–Reproductive–factors–and–non-Hodgkin– 27.– Cerhan–JR,–Kricker–A,–Paltiel–O,–et–al.–Medical–history,–lifestyle,– family–history,–and–occupational–risk–factors–for–diffuse–large–B-cell– lymphoma:–the–InterLymph–Non-Hodgkin–Lymphoma–Subtypes–Project.–J

• br Expanded statesa br Nonexpanded statesb

  2022-04-24

  

  Expanded statesa Nonexpanded statesb All states at diagnosis n (%) p-value p value Race White insurance Black insurance Other insurance Ethnicity Non-Hispanic insurance Hispanic insurance Percent living below the poverty levelc 1st quartile

• KIN59 br surgery was low However tracking outcomes

  2022-04-24

  

   surgery was low. However, tracking outcomes longitudinally improved the strength of our inferences by accounting for changes in functional status that occur naturally over time. Even with this sample size, we observed differences in func-tional status, minimizing the concern that this study was

178 records 5/12 page Previous Next 12345 Next 5 pages Last page